Neumora Therapeutics, Inc. (NMRA)
0.3672
-0.02
(-5.43%)
USD |
NASDAQ |
Oct 30, 16:00
0.3673
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Price to Book Value : 1.541 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.541 |
| October 29, 2026 | 1.630 |
| October 28, 2026 | 1.650 |
| October 27, 2026 | 1.545 |
| October 26, 2026 | 1.649 |
| October 23, 2026 | 1.592 |
| October 22, 2026 | 1.703 |
| October 21, 2026 | 1.746 |
| October 20, 2026 | 1.952 |
| October 19, 2026 | 1.973 |
| October 16, 2026 | 1.989 |
| October 15, 2026 | 1.792 |
| October 14, 2026 | 1.488 |
| October 13, 2026 | 1.554 |
| October 12, 2026 | 1.835 |
| October 09, 2026 | 1.997 |
| October 08, 2026 | 2.014 |
| October 07, 2026 | 1.966 |
| October 06, 2026 | 1.977 |
| October 05, 2026 | 2.205 |
| October 02, 2026 | 2.098 |
| October 01, 2026 | 2.308 |
| September 30, 2026 | 2.502 |
| September 29, 2026 | 2.844 |
| September 28, 2026 | 2.904 |
| Date | Value |
|---|---|
| September 25, 2026 | 2.844 |
| September 24, 2026 | 2.951 |
| September 23, 2026 | 3.069 |
| September 22, 2026 | 3.267 |
| September 21, 2026 | 2.904 |
| September 18, 2026 | 3.064 |
| September 17, 2026 | 3.148 |
| September 16, 2026 | 3.245 |
| September 15, 2026 | 3.489 |
| September 14, 2026 | 4.195 |
| September 11, 2026 | 4.365 |
| September 10, 2026 | 4.785 |
| September 09, 2026 | 5.036 |
| September 08, 2026 | 5.246 |
| September 04, 2026 | 5.498 |
| September 03, 2026 | 5.666 |
| September 02, 2026 | 5.792 |
| September 01, 2026 | 5.582 |
| August 31, 2026 | 5.582 |
| August 28, 2026 | 5.834 |
| August 27, 2026 | 6.212 |
| August 26, 2026 | 6.548 |
| August 25, 2026 | 6.296 |
| August 24, 2026 | 6.401 |
| August 21, 2026 | 6.841 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| EyePoint, Inc. | 0.1779 |
| Context Therapeutics, Inc. | 0.4552 |
| LENZ Therapeutics, Inc. | 0.437 |
| BioAge Labs, Inc. | 0.7167 |
| ANI Pharmaceuticals, Inc. | 2.770 |
Price to Book Value Related Metrics
| Price | 0.3672 |
| Earnings Yield | -335.9% |
| Market Cap | 68.61M |